AVD - NYSE

American Vanguard Corporation

AVD·NYSE

$2.47

-3.5%

Basic MaterialsAgricultural Inputs

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. The company was incorporated in 1969 and is headquartered in Newport Beach, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$70.66M

EPS-1.7500

P/E Ratio-1.41

Earnings Date07/30/2026

596.54M

Assets

-6%

3Y-18.0%

5Y-12.0%

10Y+39.0%

404.14M

Total Liabilities

3Y+13.0%

5Y+26.0%

10Y+174.0%

192.40M

Total Equity

-17%

3Y-48.0%

5Y-47.0%

10Y-32.0%

American Vanguard Corporation Funding & Solvency Profile

AVD · NYSE

Current Assets

Cash & Cash Equivalents12.43M

Net Receivables167.79M

Inventory176.03M

Other Current Assets4.61M

Total Current Assets371 M

Non-Current Assets

Property, Plant & Equipment69.83M

Goodwill & Intangible Assets138.75M

Long-Term Investments0.00

Other Non-Current Assets14.80M

Total Non-Current Assets85 M

Total Assets

596.54M

Financial Health Analysis

Current Ratio

1.77x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

2.10x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

161 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

62% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

American Vanguard Corporation Balance Sheet

AVD • NYSE

American Vanguard Corporation Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	12.4M	12.5M	11.4M	20.3M	16.3M	15.9M	6.6M	6.2M	11.3M	7.9M	5.5M	4.9M	6.7M	38.5M	35.1M	1.2M	383K	1.2M	3.2M	1.8M
Cash & Short-Term Investments	12.4M	12.5M	11.4M	20.3M	16.3M	15.9M	6.6M	6.2M	11.3M	7.9M	5.5M	4.9M	6.7M	38.5M	35.1M	1.2M	383K	1.2M	3.2M	1.8M
Net Receivables	167.8M	179.5M	194.8M	168.2M	158.9M	131.8M	155.8M	134M	109.6M	87.2M	75.4M	94.4M	85M	77.3M	70M	40.8M	44.6M	52M	56.6M	75.7M
Accounts Receivables	167.8M	169.7M	182.6M	156.5M	149.3M	131.8M	142.2M	123.3M	102.5M	83.8M	72.8M	86M	74.1M	76.1M	68.6M	33.8M	40.7M	51.4M	55.9M	75.2M
Other Receivables	0.0	9.7M	12.2M	11.7M	9.6M	0.0	13.7M	10.7M	7.1M	3.4M	2.6M	2.4M	892K	1.2M	1.2M	263K	4M	563K	645K	586K
Inventory	176M	179.3M	219.6M	184.2M	154.3M	163.8M	163.3M	159.9M	123.1M	120.6M	136.5M	165.6M	139.8M	88M	71.1M	74.1M	72.5M	90.6M	63.5M	66.6M
Prepaids	9.7M	7.6M	6.3M	15.9M	12.5M	10.5M	10.5M	10.1M	10.8M	11.4M	11.2M	13.4M	11.4M	13.7M	2.3M	2.6M	2.1M	1.7M	2.2M	1.4M
Other Current Assets	4.6M	0.0	0.0	0.0	0.0	8.3M	0.0	0.0	0.0	0.0	0.0	8.7M	6.5M	4.9M	0.0	0.0	0.0	0.0	0.0	0.0
Total Current Assets	370.5M	378.9M	432M	388.6M	342M	330.3M	336.2M	310.2M	254.9M	227.1M	236.8M	287M	249.5M	222.3M	178.5M	118.6M	119.7M	145.5M	125.4M	145.6M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	69.8M	77.9M	97M	95.2M	91.5M	77.6M	67.8M	49.3M	49.3M	50.3M	48M	50M	52.5M	45.7M	39.3M	40.5M	39.2M	41.2M	36.5M	36.9M
Goodwill	0.0	19.7M	51.2M	47M	46.3M	52.1M	46.6M	25.8M	22.2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	138.7M	150.5M	172.5M	184.7M	197.8M	197.5M	198.4M	186.6M	181M	121.4M	129.2M	100.2M	107M	113.5M	116.2M	115.2M	87M	93.2M	85.3M	79M
Goodwill & Intangible Assets	138.7M	170.2M	223.7M	231.7M	244.1M	249.6M	244.9M	212.4M	203.1M	121.4M	129.2M	100.2M	107M	113.5M	116.2M	115.2M	87M	93.2M	85.3M	79M
Long-Term Investments	0.0	0.0	0.0	0.0	4.4M	1.9M	-19.1M	-16M	-16.3M	-6.7M	-8.1M	-8.7M	-6.5M	-4.9M	-15.2M	-10.5M	-5.1M	-6.1M	-2.4M	-1.4M
Tax Assets	2.6M	1.2M	0.0	141K	270K	0.0	19.1M	16M	16.3M	6.7M	8.1M	8.7M	6.5M	4.9M	15.2M	10.5M	5.1M	6.1M	2.4M	1.4M
Other Non-Current Assets	14.8M	8.5M	14.8M	10.8M	11.9M	20.9M	21.2M	21.8M	28.3M	31.2M	29.6M	35.9M	38.5M	18.4M	5.2M	7.4M	8.9M	7M	1.3M	913K
Total Non-Current Assets	226M	257.8M	335.5M	337.7M	352.2M	350M	333.9M	283.4M	280.7M	202.9M	206.7M	186.1M	197.9M	177.6M	160.7M	163.2M	135M	141.4M	123.1M	116.8M
Total Assets	596.5M	636.7M	767.5M	726.3M	694.2M	680.3M	670.1M	593.6M	535.6M	430M	443.5M	473.2M	447.4M	399.9M	339.1M	281.8M	254.7M	286.9M	248.6M	262.4M
LIABILITIES
CURRENT LIABILITIES
Total Payables	90.1M	72.1M	74.4M	69M	70.1M	59.3M	64.9M	70.6M	55.1M	38.2M	27.8M	20.4M	40.7M	34.2M	23.2M	14M	12M	18M	13.8M	15.7M
Accounts Payable	87.5M	69.2M	68.8M	69M	67.1M	59.3M	64.9M	66.5M	53.7M	24.4M	15.3M	20.4M	40.7M	32.8M	23.2M	14M	11.4M	14.6M	13.8M	15.7M
Other Payables	2.6M	2.9M	5.6M	0.0	3M	0.0	0.0	4M	1.4M	13.8M	12.4M	0.0	0.0	1.3M	0.0	0.0	1.1M	3.3M	0.0	0.0
Accrued Expenses	0.0	101.4M	84.4M	81.7M	84M	61.6M	60.5M	53.3M	51.1M	55M	51.5M	58.5M	63.8M	41M	32.7M	23.2M	31M	23M	30.5M	23.3M
Short Term Debt	5.8M	0.0	0.0	0.0	0.0	0.0	4.9M	0.0	0.0	0.0	55K	71K	69K	16.2M	14.5M	8.4M	8.5M	7.7M	4.1M	4.1M
Capital Lease Obligations (Current)	0.0	6.1M	6.1M	5.3M	5.1M	4.2M	4.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	2.6M	2.9M	5.6M	0.0	3M	0.0	0.0	4M	1.4M	13.8M	12.4M	0.0	0.0	1.3M	0.0	0.0	0.0	3.3M	1.8M	3.3M
Deferred Revenue	0.0	52.7M	65.6M	110.6M	63.1M	0.0	6.8M	20M	14.6M	3.8M	8.9M	898K	3.8M	20.4M	7.6M	5.6M	0.0	23M	30.5M	23.3M
Other Current Liabilities	113.6M	0.0	0.0	0.0	802K	46.3M	-3.4M	1.6M	5.4M	26K	514K	1.4M	2.1M	1.8M	1M	0.0	-557K	0.0	1.8M	3.3M
Total Current Liabilities	209.4M	232.4M	230.5M	266.6M	223.1M	171.3M	138.6M	145.5M	126.2M	97.1M	76.3M	81.2M	110.5M	113.7M	79M	51.2M	50.9M	48.6M	50.3M	46.3M
NON-CURRENT LIABILITIES
Long Term Debt	174M	147.3M	138.9M	51.5M	52.2M	107.4M	148.8M	96.7M	77.5M	41M	68.3M	99.5M	51.7M	36.2M	51.9M	53.7M	45.4M	76.3M	56.2M	93.8M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-6.1M	-2.4M	-1.4M
Deferred Tax Liabilities (Non-Current)	8.2M	8M	7.9M	14.6M	20M	0.0	19.1M	15.4M	16.3M	6.7M	27.6M	28.2M	23.3M	19.2M	15.2M	10.5M	5.1M	6.1M	2.4M	1.4M
Other Non-Current Liabilities	923K	1.6M	3.1M	4.2M	5.3M	32.6M	12.9M	6.8M	10.3M	2.9M	3.1M	3.3M	4.1M	5.4M	21.1M	3K	192K	0.0	0.0	0.0
Total Non-Current Liabilities	194.7M	171.3M	167M	89.7M	98.4M	148.2M	187.3M	118.8M	104.1M	50.5M	98.9M	130.9M	79.1M	60.8M	73M	64.2M	50.7M	82.4M	58.5M	95.2M
Capital Lease Obligations	11.6M	20.5M	23.2M	24.8M	25.8M	12.4M	11.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	404.1M	403.6M	397.5M	356.3M	321.4M	319.6M	325.9M	264.4M	230.3M	147.6M	175.2M	212.2M	189.6M	174.5M	152.1M	115.4M	101.6M	131M	108.8M	141.5M
SHAREHOLDERS' EQUITY
Treasury Stock	-71.2M	-71.2M	-71.2M	-55.7M	-22.7M	-18.2M	-18.2M	-15.6M	-8.3M	-8.3M	-8.3M	-8.3M	-6.7M	-4.8M	-3.2M	-3.2M	-3.2M	-3.2M	-2.7M	-2.7M
Common Stock	3.5M	3.5M	3.5M	3.4M	3.4M	3.4M	3.3M	3.3M	3.2M	3.2M	3.2M	3.2M	3.1M	3.1M	3M	3M	3M	2.9M	2.9M	2.8M
Additional Paid-In Capital	117.1M	114.7M	110.8M	105.6M	101.5M	96.6M	90.6M	83.2M	75.7M	71.7M	68.5M	66.2M	60.2M	54.3M	46M	43.4M	41.5M	38.9M	36.6M	34.8M
Retained Earnings	155M	204.9M	332.9M	328.7M	304.4M	288.2M	274.1M	262.8M	239M	220.4M	208.5M	202.5M	202.5M	174.2M	143.5M	123.7M	113.5M	120.9M	103M	86.1M
Accumulated Other Comprehensive Income/Loss	-12M	-18.7M	-6M	-12.2M	-13.8M	-9.3M	-5.7M	-4.5M	-4.5M	-4.9M	-3.5M	-2M	-1M	-1.8M	-2.3M	-448K	-1.7M	-3.6M	64K	-148K
Total Stockholders' Equity	192.4M	233.1M	370M	370M	372.7M	360.7M	344.2M	329.2M	305.1M	282.2M	268.4M	261.6M	258M	225.1M	187.1M	166.4M	153.1M	155.9M	139.7M	120.9M
Total Equity	192.4M	233.1M	370M	370M	372.7M	360.7M	344.2M	329.2M	305.3M	282.4M	268.3M	261M	257.8M	225.4M	187.1M	166.4M	153.1M	155.9M	139.7M	120.9M
Minority Interest	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	254K	167K	-69K	-634K	-158K	359K	0.0	0.0	0.0	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	596.5M	636.7M	767.5M	726.3M	694.2M	680.3M	670.1M	593.6M	535.6M	430M	443.5M	473.2M	447.4M	399.9M	339.1M	281.8M	254.7M	286.9M	248.6M	262.4M
Total Investments	0.0	0.0	0.0	0.0	4.4M	1.9M	-19.1M	-16M	-16.3M	-6.7M	-8.1M	-8.7M	-6.5M	-4.9M	-15.2M	-10.5M	-5.1M	-6.1M	-2.4M	-1.4M
Total Debt	191.4M	167.8M	162.1M	76.2M	78.1M	119.8M	160.2M	96.7M	77.5M	41M	68.4M	99.5M	51.7M	52.4M	66.4M	62.1M	54M	84M	60.3M	97.9M
Net Debt	179M	155.3M	150.7M	55.9M	61.8M	103.9M	153.6M	90.5M	66.1M	33.1M	62.9M	94.6M	45.1M	14M	31.3M	61M	53.6M	82.8M	57.1M	96M
Shares Outstanding	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276	28,431,276

SEC Filings

AVD - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 06, 2026	March 31, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 23, 2026	June 03, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 15, 2026	April 10, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 19, 2026	March 13, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 18, 2026	March 16, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 16, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 12, 2025	November 10, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 10, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	August 19, 2025	August 18, 2025	2025	View Filing
8-K 8-K 2025 N/A	August 01, 2025	July 31, 2025	2025	View Filing

Showing 1 to 10 of 456 filings

Related Guides

Blog Categories

Continue your AVD research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.